178 related articles for article (PubMed ID: 9675606)
1. Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease.
Edelstam G; Lecander I; Larsson B; Astedt B
Inflammation; 1998 Aug; 22(4):341-51. PubMed ID: 9675606
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease.
Dörr PJ; Brommer EJ; Dooijewaard G; Vemer HM
Thromb Haemost; 1992 Aug; 68(2):102-5. PubMed ID: 1412151
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis: the key to new pathogenetic mechanisms.
Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
[TBL] [Abstract][Full Text] [Related]
4. A role for the fibrinolytic system in postsurgical adhesion formation.
Hellebrekers BW; Emeis JJ; Kooistra T; Trimbos JB; Moore NR; Zwinderman KH; Trimbos-Kemper TC
Fertil Steril; 2005 Jan; 83(1):122-9. PubMed ID: 15652897
[TBL] [Abstract][Full Text] [Related]
5. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal fluid plasminogen activator activity in endometriosis and pelvic adhesive disease.
Batzofin JH; Holmes SD; Gibbons WE; Buttram VC
Fertil Steril; 1985 Aug; 44(2):277-9. PubMed ID: 4040480
[TBL] [Abstract][Full Text] [Related]
7. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.
Molinas CR; Elkelani O; Campo R; Luttun A; Carmeliet P; Koninckx PR
Fertil Steril; 2003 Jul; 80(1):184-92. PubMed ID: 12849822
[TBL] [Abstract][Full Text] [Related]
8. Human intraperitoneal fibrinolytic response to elective surgery.
Scott-Coombes D; Whawell S; Vipond MN; Thompson J
Br J Surg; 1995 Mar; 82(3):414-7. PubMed ID: 7796030
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal fibrinolytic activity and adhesiogenesis.
Fometescu SG; Costache M; Coveney A; Oprescu SM; Serban D; Savlovschi C
Chirurgia (Bucur); 2013; 108(3):331-40. PubMed ID: 23790781
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal fibrinolytic response to various aspects of laparoscopic surgery: a randomized trial.
Brokelman WJ; Holmdahl L; Bergström M; Falk P; Klinkenbijl JH; Reijnen MM
J Surg Res; 2006 Dec; 136(2):309-13. PubMed ID: 17054995
[TBL] [Abstract][Full Text] [Related]
11. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery.
Shimomura M; Hinoi T; Ikeda S; Adachi T; Kawaguchi Y; Tokunaga M; Sasada T; Egi H; Tanabe K; Okajima M; Ohdan H
Surgery; 2013 Mar; 153(3):344-56. PubMed ID: 23218127
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts.
Ueyama M; Kasatori N; Urayama T; Maemura T; Yao Y; Shiraishi T; Saito S; Kubo H
Thromb Res; 2002 Nov; 108(4):235-44. PubMed ID: 12617987
[TBL] [Abstract][Full Text] [Related]
13. Regulation of equine fibrinolysis in blood and peritoneal fluid based on a study of colic cases and induced endotoxaemia.
Collatos C; Barton MH; Schleef R; Prasse KW; Moore JN
Equine Vet J; 1994 Nov; 26(6):474-81. PubMed ID: 7889922
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women.
Bruse C; Bergqvist A; Carlström K; Fianu-Jonasson A; Lecander I; Astedt B
Fertil Steril; 1998 Nov; 70(5):821-6. PubMed ID: 9806560
[TBL] [Abstract][Full Text] [Related]
15. The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation.
Zeyneloglu HB; Senturk LM; Seli E; Oral E; Olive DL; Arici A
Hum Reprod; 1998 May; 13(5):1194-9. PubMed ID: 9647546
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator/plasminogen activator inhibitor-1 and cytokine modulation by the PROACT System.
Ivarsson ML; Diamond MP; Falk P; Holmdahl L
Fertil Steril; 2003 Apr; 79(4):987-92. PubMed ID: 12749442
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.
Casslén B; Bossmar T; Lecander I; Astedt B
Eur J Cancer; 1994; 30A(9):1302-9. PubMed ID: 7999418
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.
Braza-Boïls A; Gilabert-Estellés J; Ramón LA; Gilabert J; Marí-Alexandre J; Chirivella M; España F; Estellés A
PLoS One; 2013; 8(4):e62370. PubMed ID: 23620826
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
